Literature DB >> 12370047

Peptidomimetics and peptide backbone modifications.

Jung-Mo Ahn1, Nicholas A Boyle, Mary T MacDonald, Kim D Janda.   

Abstract

The replacement of the amide bond in a peptide backbone is a widely used form of peptide mimicry. Several of the most common amide bond surrogates, including peptidomimetic work done in this laboratory, and their biological applications are presented in this review.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12370047     DOI： 10.2174/1389557023405828

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN： 1389-5575            Impact factor:   3.862


  15 in total

1.  Universal peptidomimetics.

Authors:  Eunhwa Ko; Jing Liu; Lisa M Perez; Genliang Lu; Amber Schaefer; Kevin Burgess
Journal:  J Am Chem Soc       Date:  2010-12-23       Impact factor: 15.419

2.  Heterocyclic peptide backbone modifications in an alpha-helical coiled coil.

Authors:  W Seth Horne; Maneesh K Yadav; C David Stout; M Reza Ghadiri
Journal:  J Am Chem Soc       Date:  2004-12-01       Impact factor: 15.419

3.  Functionalization of titanium based metallic biomaterials for implant applications.

Authors:  Rahul Bhola; Fengyun Su; Catherine E Krull
Journal:  J Mater Sci Mater Med       Date:  2011-04-08       Impact factor: 3.896

Review 4.  Tetrahydrofuran, tetrahydropyran, triazoles and related heterocyclic derivatives as HIV protease inhibitors.

Authors:  Arun K Ghosh; David D Anderson
Journal:  Future Med Chem       Date:  2011-07       Impact factor: 3.808

Review 5.  Biological nano-functionalization of titanium-based biomaterial surfaces: a flexible toolbox.

Authors:  René Beutner; Jan Michael; Bernd Schwenzer; Dieter Scharnweber
Journal:  J R Soc Interface       Date:  2009-11-04       Impact factor: 4.118

6.  Synthesis and crystal structure of new heterocyles derived from saccharin and uracil carrying 1,2,4-oxadiazolylmethyl group.

Authors:  Yaşar Dürüst; Besra Özer; Benson M Kariuki; Benson M Cariuki
Journal:  Mol Divers       Date:  2015-03-10       Impact factor: 2.943

7.  Developing potent backbone cyclic peptides bearing the shared epitope sequence as rheumatoid arthritis drug-leads.

Authors:  Shirly Naveh; Yftah Tal-Gan; Song Ling; Amnon Hoffman; Joseph Holoshitz; Chaim Gilon
Journal:  Bioorg Med Chem Lett       Date:  2011-11-04       Impact factor: 2.823

8.  Synthesis and crystal structure of new heterocycles containing 1,2,4-oxadiazole, 1,2,4-oxadiazolone (thione), hydantoin, and mercaptobenzimidazole units.

Authors:  Yaşar Dürüst; Özge Gözlükaya; Gülsün Özer; Frank R Fronczek
Journal:  Mol Divers       Date:  2014-05-04       Impact factor: 2.943

9.  Peptidomimetic targeting of critical androgen receptor-coregulator interactions in prostate cancer.

Authors:  Preethi Ravindranathan; Tae-Kyung Lee; Lin Yang; Margaret M Centenera; Lisa Butler; Wayne D Tilley; Jer-Tsong Hsieh; Jung-Mo Ahn; Ganesh V Raj
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 10.  Conversion of Protein Active Regions into Peptidomimetic Therapeutic Leads Using Backbone Cyclization and Cycloscan - How to Do it Yourself!

Authors:  Samuel J S Rubin; Yftah Tal-Gan; Chaim Gilon; Nir Qvit
Journal:  Curr Top Med Chem       Date:  2018       Impact factor: 3.295
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.